一个是试点研究，另一个是前瞻性、非随机、无对照试验研究，其中60％的患者能达到眼内压<21mmHg，并且不需要青光眼药物治疗。
One was a pilot study, and another was a prospective, non-randomized, non-controlled trial in which IOP <21 mm Hg was able to be achieved in 60% of the patients, without glaucoma medication.
专家组的决定立足于一项历时5年，随访时间为12个月，包含149例肥胖患者的无对照非随机临床试验。
The Panel's decision was based on 12-month data from a 5-year, single-arm, non-randomized trial involving 149 obese individuals.
结果：对皮肤无刺激性，亦无变态反应发生，在消炎和止痛两项试验中，试验组与对照组比较，差异有显著性。
Results: none stimulation to derma, none derma feedback to anomalism, in experiments of anti-inflammation and acesodyne, there was great difference between experimental group and control group.
试验动物血液常规检验项目和各项血液生化指标与对照组无差异性，均在正常范围；各剂量组动物脏器病理检查未发现病理改变。
The blood routine examination items and all blood biochemical indices of the experimental animals were not different from those of the control group and were within the norm.
比较止吐剂和安慰剂或无治疗，用于治疗18岁以下的儿童和青少年肠胃炎引发呕吐的随机对照试验。
Randomized controlled trials comparing antiemetics with placebo or no treatment, in children and adolescents under the age of 18, for vomiting due to gastroenteritis.
方法80例不明原因晕厥患者为病人组，47例无晕厥病史的健康人作为对照组均采用此试验，包括基础倾斜试验和异丙肾倾斜试验。
Method 80 patients with unexplained syncope and 47 healthy controls were tested, including basic tilt table test and isoproterenol tilt table test.
同时，进行了28天大鼠喂养试验和8天鹌鹑喂养试验。结果显示：各试验组体重、食物利用率与对照组无显著差异，受试动物生长发育及行为正常，无死亡。
In a 28 day feeding test with rats and a 8 day feeding test with quail, no adverse effects on rats or quails were observed in terms of animal behavior, weight gain and feed utilization rate.
小鼠骨髓细胞微核试验中高剂量组与空白对照组差异显著（P〈0.05），高、中、低剂量组间无显著差异；
The organ coefficient of kidney of the male mice were lower obviously than the control group(P<0.05).
为检测试验条件是否符合要求，取试验用稀释液代替供试品做一阴性对照试验，阴性对照试验应无微生物生长。
To verify testing conditions, a negative control is performed using the chosen diluent in place of the test preparation. There must be no growth of micro-organisms.
受试者中至少50%无冠心病病史，随访大于等于12个月的随机对照试验入选本次分析。
Randomized controlled trials with a study population with at least 50% of the subjects having no history of coronary heart disease and 12 or more months of follow-up were included.
一项6年对照临床试验在1,277位无癌性PAD患者中检测了通过静脉切开术减少铁的作用。
Effects of iron reduction by phlebotomy were tested in a 6-year, controlled clinical trial in 1,277 cancer-free PAD patients.
试验组的不良反应的发生率为14 % ，与对照组相比无显著意义（P >0 .0 5 ）。
The rate of adverse reactions in ELof group was 14 %, which had no significant difference compared with that of the diazepam group (P>0.05).
结果试验总完成率95%，其中治疗组2例、对照组4例脱落，无患者因不耐受药物而脱落。
Results the trial was completed in 95% of the patients, 2 patients withdrew in the VASOREL group and 4 patients in the control group; but none for the intolerable therapy.
心绞痛疗效比较显示试验组总有效率为90.0％，对照组总有效率为70.0％，组间对照无显著性差异（P＜0.05）；
The angina pectoris clinical efficacy rate has differences between two groups (P<0.05) for the treatment group is 90.0% and the control group is 70.0%.
②试验组在改善过敏性紫癜患者的皮肤紫癜、关节疼痛和腹痛方面能够取得与对照组相近的效果，与对照组相比无显著性差异（P>0.05）；
The time of skin purpura regression, the arthrodynia regression and the abdominalgia egression compared with the control group treated by prednisone has no significant difference(P>0.05);
前瞻性血小板聚集率测定试验：对照组和联用组临床基线资料无显著差异。
There were no significant differs in the baseline level or 72h value after PCI of the maximum platelet aggregation rate (MPAR) between the two groups.
前瞻性血小板聚集率测定试验：对照组和联用组临床基线资料无显著差异。
There were no significant differs in the baseline level or 72h value after PCI of the maximum platelet aggregation rate (MPAR) between the two groups.
应用推荐